logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Melinda L. Telli

Vanderbilt University
H指数:56
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Breast Cancer, Version 5.2025 Featured Updates to the NCCN Guidelines

Gradishar, W.J.; Moran, M.S.; Abraham, J.; Abranson, V.; Aft, R.; Agnese, D.; Allison, K.H.; Anderson, B.; Bailey, J.; Burstein, H.J.; et al. NCCN指南，乳腺癌，版本5。J. Natl. Compr. Cancer Netw. 2025, 23, 426–436. [Google Scholar] [CrossRef]

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2025-11-013
PRE
Gradishar, William J.; Moran, Meena S.; Abraham, Jame; Abramson, Vandana; Aft, Rebecca; Agnese, Doreen; Allison, Kimberly H.; Anderson, Bethany; Bailey, Janet; Burstein, Harold J.; Chen, Nan; Chew, Helen; Dang, Chau; Elias, Anthony D.; Giordano, Sharon H.; Goetz, Matthew P.; Jankowitz, Rachel C.; Javid, Sara H.; Krishnamurthy, Jairam; Leitch, A. Marilyn; Lyons, Janice; McCloskey, Susie; McShane, Melissa; Mortimer, Joanne; Patel, Sameer A.; Rosenberger, Laura H.; Rugo, Hope S.; Santa-Maria, Cesar A.; Schneider, Bryan P.; Smith, Mary Lou; Soliman, Hatem; Stringer-Reasor, Erica M.; Telli, Melinda L.; Wei, Mei; Wisinski, Kari B.; Yellala, Amulya; Yeung, Kay T.; Young, Jessica S.; Schonfeld, Ryan; Kumar, Rashmi
A 20-feature radiomic signature of triple-negative breast cancer identifies patients at high risk of death

三阴性乳腺癌的20个特征的放射组学特征可识别死亡高风险患者

npj Breast Cancer
IF7.6
2025-07-260
OAAI
Humaira Noor; Yuanning Zheng; Adam B. Mantz; Ryle Zhou; Andrew Kozlov; Wendy B. DeMartini; Shu-Tian Chen; Satoko Okamoto; Debra M. Ikeda; Melinda L. Telli; Allison W. Kurian; James M. Ford; Shaveta Vinayak; Mina Satoyoshi; Vishal Joshi; Sarah A. Mattonen; Kevin Lee; Olivier Gevaert; George W. Sledge; Haruka Itakura
Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium

乳腺癌管理中的争议与关键知识空白专家观点：第一届弥合乳腺癌知识空白研讨会的会议录

Clinical Breast Cancer
IF2.5
2025-04-080
PRE
Komal Jhaveri; Carey K. Anders; Aditya Bardia; Manali Bhave; A. Jo Chien; Ian Krop; Tiffany A. Traina; Yara Abdou; Reva Basho; Alison K. Conlin; Francisco J. Esteva; Kevin R. Fox; Vijayakrishna Gadi; Peter A. Kaufman; Anya Litvak; Cynthia X. Ma; Eleftherios P. Mamounas; Heather McArthur; Kelly McCann; Zahi Mitri; Rebecca Shatsky; Melinda Telli; Mylin A. Torres; Kevin Kalinsky
Breast Cancer, Version 3.2024
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2024-07-0120
PRE
Gradishar, William J.; Moran, Meena S.; Abraham, Jame; Abramson, Vandana; Aft, Rebecca; Agnese, Doreen; Allison, Kimberly H.; Anderson, Bethany; Bailey, Janet; Burstein, Harold J.; Chen, Nan; Chew, Helen; Dang, Chau; Elias, Anthony D.; Giordano, Sharon H.; Goetz, Matthew P.; Jankowitz, Rachel C.; Javid, Sara H.; Krishnamurthy, Jairam; Leitch, A. Marilyn; Lyons, Janice; McCloskey, Susie; Mcshane, Melissa; Mortimer, Joanne; Patel, Sameer A.; Rosenberger, Laura H.; Rugo, Hope S.; Santa-Maria, Cesar; Schneider, Bryan P.; Smith, Mary Lou; Soliman, Hatem; Stringer-Reasor, Erica M.; Telli, Melinda L.; Wei, Mei; Wisinski, Kari B.; Yeung, Kay T.; Young, Jessica S.; Schonfeld, Ryan; Kumar, Rashmi
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status
BREAST CANCER
IF2.9
2024-06-137
OAAI
Telli, Melinda L.; Litton, Jennifer K.; Beck, J. Thaddeus; Jones, Jason M.; Andersen, Jay; Mina, Lida A.; Brig, Raymond; Danso, Michael; Yuan, Yuan; Symmans, William F.; Hopkins, Julia F.; Albacker, Lee A.; Abbattista, Antonello; Noonan, Kay; Mata, Marielena; Laird, A. Douglas; Blum, Joanne L.
MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Jung, Kyung Hae; Im, Seock-Ah; Yardley, Denise; Hurvitz, Sara; Lee, Keun Seok; Sonnenblick, Amir; Shachar, Shlomit; Tan, Antoinette; Comen, Elizabeth; Gal-Yam, Einav; Brufsky, Adam; Rugo, Hope; Zhu, Jing; DuPree, Kelly; Breton, Vanessa; Young, Fiona; Schwab, Richard; Cha, Edward; Telli, Melinda
Updated results from VERITAC evaluating vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, in ER- positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer

VERITAC评估ER阳性/人表皮生长因子受体2 (HER2) 阴性晚期乳腺癌中蛋白水解靶向嵌合体 (PROTAC) 雌激素受体 (ER) 降解剂vepdegestrant的更新结果

CANCER RESEARCH
IF16.6
2024-05-021
PRE
Hurvitz, Sara; Schott, Anne; Ma, Cynthia; Nanda, Rita; Zahrah, George; Hunter, Natasha; Tan, Antoinette; Telli, Melinda; Mesias, Jesus Anampa; Jeselsohn, Rinath; Munster, Pamela; Zhi, Eric; Duperret, Elizabeth; Mather, Cecile; Hamilton, Erika; Han, Hyo
Phase 3 study of neoadjuvant pembrolizumab or placebo plus chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/ HER2-breast cancer: KEYNOTE-756
CANCER RESEARCH
IF16.6
2024-05-026
PRE
Cardoso, Fatima; O'Shaughnessy, Joyce; McArthur, Heather; Schmid, Peter; Cortes, Javier; Harbeck, Nadia; Telli, Melinda; Cescon, David; Fasching, Peter A.; Shao, Zhimin; Loirat, Delphine; Park, Yeon Hee; Fernandez, Manuel Gonzalez; Rubovszky, Gabor; Im, Seock-Ah; Hui, Rina; Takano, Toshimi; Andre, Fabrice; Yasojima, Hiroyuki; Liu, Zhenzhen; Ding, Yu; Jia, Liyi; Karantza, Vassiliki; Tryfonidis, Konstantinos; Bardia, Aditya
KEYNOTE-756: Phase III study of neoadjuvant pembrolizumab (pembro) or placebo (pbo) plus chemotherapy (chemo), followed by adjuvant pembro or pbo plus endocrine therapy (ET) for early-stage high-risk ER+/HER2e breast cancer
ANNALS OF ONCOLOGY
IF65.4
2023-10-0153
PRE
Cardoso, F.; McArthur, H. L.; Schmid, P.; Cortes, J.; Harbeck, N.; Telli, M. L.; Cescon, D. W.; O'Shaughnessy, J.; Fasching, P.; Shao, Z.; Loirat, D.; Park, Y. H.; Fernandez, M. E. Gonzalez; Liu, Z.; Yasojima, H.; Ding, Y.; Jia, L.; Karantza, V. V.; Tryfonidis, K. E.; Bardia, A.

研究方向

暂未获取到该数据
J
James M. Ford
H 指数:99论文数:685被引数:3.1万
W
William J. Gradishar
H 指数:78论文数:1,302被引数:3.1万
S
Shaveta Vinayak
H 指数:25论文数:126被引数:3,718
M
Matthew P. Goetz
H 指数:81论文数:892被引数:3.2万
H
Hatem Soliman
H 指数:45论文数:278被引数:1.2万
H
Hope S. Rugo
H 指数:137论文数:1,616被引数:10.0万
H
Harold J. Burstein
H 指数:102论文数:446被引数:5.2万
S
Sharon H. Giordano
H 指数:99论文数:675被引数:3.8万
A
Anthony Elias
H 指数:71论文数:492被引数:2.3万
M
Meena S. Moran
H 指数:46论文数:222被引数:1.4万